North Star Investment Management’s Idexx Laboratories IDXX Stock Holding History

North Star Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$562	Sell	1 -2	-67%	-$1.28K	﹤0.01%	1576
2025 Q4	$2.03K	Buy	+3	New	+$2.04K	﹤0.01%	1331
2024 Q2	–	Sell	-4	Closed	-$2.16K	–	1202
2024 Q1	$2.16K	Hold	4	–	–	﹤0.01%	1081
2023 Q4	$2.22K	Hold	4	–	–	﹤0.01%	1039
2023 Q3	$1.75K	Hold	4	–	–	﹤0.01%	1075
2023 Q2	$2.01K	Hold	4	–	–	﹤0.01%	1070
2023 Q1	$2K	Hold	4	–	–	﹤0.01%	1084
2022 Q4	$1.63K	Buy	+4	New	+$1.55K	﹤0.01%	1101
2017 Q3	–	Sell	-270	Closed	-$44K	–	1104
2017 Q2	$44K	Buy	270 +10	+4%	+$1.62K	0.01%	563
2017 Q1	$40K	Hold	260	–	–	0.01%	558
2016 Q4	$30K	Buy	+260	New	+$29.7K	﹤0.01%	571

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

North Star Investment Management's IDXX Position: Q1 2026 in Review

North Star Investment Management reduced its Idexx Laboratories (IDXX) stake by 67% in Q1 2026, selling an estimated $1.28K and leaving 1 share worth $562. The position accounts for ﹤0.01% of the portfolio, ranked #1576.

North Star Investment Management first reported a position in IDXX in Q4 2016 and has held it in 11 quarters since. The position peaked at $44K in Q2 2017. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

North Star Investment Management held 1 share of Idexx Laboratories worth $562 as of Q1 2026.
North Star Investment Management sold 2 Idexx Laboratories shares in Q1 2026, an estimated $1.28K.
Idexx Laboratories made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #1576 holding.
North Star Investment Management first reported a position in Idexx Laboratories in Q4 2016 and has held it in 11 quarters since.
North Star Investment Management's Idexx Laboratories position peaked at $44K in Q2 2017.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.